John Najim
Chief Tech/Sci/R&D Officer bij DYNE THERAPEUTICS, INC.
Profiel
John Najim is currently the Chief Technical Officer at Dyne Therapeutics, Inc. Prior to his current position, he worked as an Associate Director-Manufacturing at Dyax Corp.
and as the VP-Manufacturing & Process Development at Proteon Therapeutics, Inc. from 2009 to 2019.
Mr. Najim holds an MBA from Bentley University and an undergraduate degree from Merrimack College.
Actieve functies van John Najim
| Bedrijven | Functie | Begin |
|---|---|---|
| DYNE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01-08-2019 |
Eerdere bekende functies van John Najim
| Bedrijven | Functie | Einde |
|---|---|---|
| PROTARA THERAPEUTICS, INC. | Corporate Officer/Principal | 01-05-2019 |
| DYAX CORP. | Corporate Officer/Principal | - |
Opleiding van John Najim
| Bentley University | Masters Business Admin |
| Merrimack College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| DYNE THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Dyax Corp.
 Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
Proteon Therapeutics, Inc.
 Proteon Therapeutics, Inc. BiotechnologyHealth Technology Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease. The company was founded by F. Nicholas Franano and William P. Whitaker in 2001 and is headquartered in Waltham, MA. | Health Technology |
